Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease

Radiology

Volumn 265, Issue 2, 2012, Pages 600-610

  Kirby, Miranda ^a,b   Svenningsen, Sarah ^a,b   Owrangi, Amir ^a,c   Wheatley, Andrew ^a   Farag, Adam ^a   Ouriadov, Alexei ^a   Santyr, Giles E ^a,b   Etemad Rezai, Roya ^b   Coxson, Harvey O ^e   McCormack, David G ^a,d   Parraga, Grace ^a,b,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b Department of Medical Biophysics ^*  (Canada)

^c Graduate Program in Biomedical Engineering   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HELIUM; HELIUM 3; UNCLASSIFIED DRUG; XENON; XENON 129; CONTRAST MEDIUM; DIAGNOSTIC AGENT; ISOTOPE;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HELIUM NUCLEAR MAGNETIC RESONANCE; HUMAN; HYPERPOLARIZATION; INTERMETHOD COMPARISON; LUNG CAPACITY; LUNG DIFFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLETHYSMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; VENTILATION DEFECT PERCENTAGE; VOLUNTEER; XENON NUCLEAR MAGNETIC RESONANCE; AEROSOL; CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATIC ELECTRICITY;

ADMINISTRATION, INHALATION; AEROSOLS; AGED; CONTRAST MEDIA; FEMALE; HELIUM; HUMANS; ISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATIC ELECTRICITY; XENON ISOTOPES;

EID: 84867910322     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120485     Document Type: Article

References (58)

1. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP III. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes - initial experience. Radiology 2002;222(1):252-260. (Pubitemid 34031496)
2. 3He MRI: preliminary clinical experience in 18 patients with and without lung disease. J Magn Reson Imaging 1997;7(3):538-543.
3. de Lange EE, Mugler JP III, Brookeman JR, et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999;210(3):851-857. (Pubitemid 29124051)
4. Möller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002;47(6):1029-1051. (Pubitemid 34587394)
5. 3He magnetic resonance imaging of ventilation defects in healthy elderly volunteers: initial findings at 3.0 Tesla. Acad Radiol 2008;15(6):776-785.
6. 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007;42(6):384-391.
7. 3He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011;79(1):140-146.
8. 3He MR imaging. Radiology 2010;256(1):280-289.
9. 3He magnetic resonance imaging-derived pulmonary pressure-volume curves. J Appl Physiol 2010;109(2):574-585.
10. de Lange EE, Altes TA, Patrie JT, et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006;130(4):1055-1062. (Pubitemid 44583735)
11. 3He MR lung ventilation imaging in asthmatics: preliminary findings. J Magn Reson Imaging 2001;13(3):378-384.
12. Samee S, Altes T, Powers P, et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003;111(6):1205-1211. (Pubitemid 36683671)
13. Tzeng YS, Lutchen K, Albert M. The difference in ventilation heterogeneity between asthmatic and healthy subjects quantified using hyperpolarized 3He MRI. J Appl Physiol 2009;106(3):813-822.
14. Fain SB, Gonzalez-Fernandez G, Peterson ET, et al. Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Acad Radiol 2008;15(6):753-762. (Pubitemid 351662749)
15. Mentore K, Froh DK, de Lange EE, Brookeman JR, Paget-Brown AO, Altes TA. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005;12(11):1423-1429. (Pubitemid 41512835)
16. 3He MRI: preliminary results in children with cystic fibrosis. J Magn Reson Imaging 2005;22(3):420-426.
17. Kirby M, Svenningsen S, Ahmed H, et al. Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis. Acad Radiol 2011;18(8):1006-1013.
18. 3He-enhanced and conventional proton MR imaging in the lung - preliminary observations. Radiology 1999;212(3):885-889.
19. 3He magnetic resonance imaging. Med Phys 2010;37(1):22-31.
20. Ireland RH, Bragg CM, McJury M, et al. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007;68(1):273-281. (Pubitemid 46589859)
21. 3He-MRI, and pulmonary function tests. Chest 2004;125(1):173-181.
22. 3He-enhanced MR imaging of lung transplant recipients: preliminary results. AJR Am J Roentgenol 1999;173(4):955-959.
23. 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla. Acad Radiol 2008;15(10):1298-1311.
24. Morbach AE, Gast KK, Schmiedeskamp J, et al. Diffusion-weighted MRI of the lung with hyperpolarized helium-3: a study of reproducibility. J Magn Reson Imaging 2005;21(6):765-774. (Pubitemid 40770869)
25. 3He apparent diffusion coefficient MRI of the lung: reproducibility and volume dependency in healthy volunteers and patients with emphysema. J Magn Reson Imaging 2008;27(4):763-770.
26. 3He apparent diffusion coefficients in severe chronic obstructive pulmonary disease. J Magn Reson Imaging 2007;26(6):1537-1547.
27. 3He diffusion MRI. J Appl Physiol 2009;107(4):1258-1265.
28. Yablonskiy DA, Sukstanskii AL, Leawoods JC, et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci U S A 2002;99(5):3111-3116. (Pubitemid 34240594)
29. Saam BT, Yablonskiy DA, Kodibagkar VD, et al. MR imaging of diffusion of (3)He gas in healthy and diseased lungs. Magn Reson Med 2000;44(2):174-179. (Pubitemid 30616020)
30. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006;239(3):875-883. (Pubitemid 43830626)
31. Fain SB, Altes TA, Panth SR, et al. Detection of age-dependent changes in healthy adult lungs with diffusion-weighted 3He MRI. Acad Radiol 2005;12(11):1385-1393. (Pubitemid 41512831)
32. 3He-MRI using MSCT and pulmonary function tests as references. Eur J Radiol 2009;71(2):257-263.
33. 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 2006;56(6):1293-1300.
34. 3He-MRI study: lacunarity analysis provided a more sensitive measure than standard ADC analysis. Acad Radiol 2009;16(6):700-707.
35. 3He MR imaging. Radiology 2011;261(1):283-292.
36. Kirby M, Heydarian M, Wheatley A, McCormack DG, Parraga G. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol 2012;112(4):651-657.
37. Walker TG, Happer W. Spin-exchange optical pumping of noble-gas nuclei. Rev Mod Phys 1997;69(2):629-642.
38. Mugler JP III, Mata JF, Wang HTJ, et al. The apparent diffusion coefficient of 129-Xe in the lung: preliminary human results [abstr]. In: Proceedings of the Twelfth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2004; 769.
39. 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn Reson Med 2011;65(4):1154-1165.
40. 3Xe MR imaging in healthy volunteers and patients. Radiology 2012;262(1):279-289.
41. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338. (Pubitemid 41079078)
42. Chen XJ, Möller HE, Chawla MS, et al. Spatially resolved measurements of hyperpolarized gas properties in the lung in vivo. I. Diffusion coefficient. Magn Reson Med 1999;42(4):721-728. (Pubitemid 29468302)
43. 3He lung MRI at 1.5T. Magn Reson Med 2008;60(2):431-438.
44. Farag A, Wang J, Ouriadov A, Parraga G, Santyr G. Unshielded and asymmetric RF transmit coil for hyperpolarized 129Xe human lung imaging at 3.0T [abstr]. In: Proceedings of the Twentieth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2012; 1233.
45. Sukstanskii AL, Yablonskiy DA. Lung morphometry with hyperpolarized 129Xe: theoretical background. Magn Reson Med 2012;67(3):856-866.
46. Boudreau M, Xu X, Santyr GE. Measurement of (129) Xe gas apparent diffusion coefficient anisotropy in an elastase-instilled rat model of emphysema. Magn Reson Med doi:10.1002/mrm.24224. Published online February 29, 2012. Accessed February 29, 2012.
47. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005;21(4):365-369. (Pubitemid 40446430)
48. 3He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012;19(2):141-152.
49. MacQueen J. Some methods for classification and analysis of multivariate observations. In: Le Cam LM, Neyman J, eds. Fifth Berkeley Symposium on Mathematical Statistics and Probability; Statistical Laboratory of the University of California, Berkeley. Berkeley, Calif: University of California Press, 1967; 281-297.
50. Adams R, Bischof L. Seeded region growing. IEEE Trans Pattern Anal Mach Intell 1994;16(6):641-647.
51. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1(8476):307-310. (Pubitemid 16134762)
52. Comrey AL, Lee HB. Confidence intervals for means and tests on correlations. In: Elementary statistics: a problem solving approach. 4th ed. Morrisville, NC: Lulu, 2009; 103-112.
53. Van Bell G, Fisher L, Heagerty P, Lumley T. Multiple comparisons in biostatistics: a methodology for the health sciences. 2nd ed. Seattle, Wash: Wiley-Interscience, 2004.
54. Shukla Y, Wheatley A, Kirby M, et al. Hyperpolarized (129)Xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. Acad Radiol 2012;19(8):941-951.
55. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555. (Pubitemid 47403272)
56. Hogg JC, Macklem PT, Thurlbeck WM. The resistance of small airways in normal and diseased human lungs. Aspen Emphysema Conf 1967;10:433-441.
57. Marshall H, Deppe MH, Parra-Robles J, et al. Direct visualisation of collateral ventilation in COPD with hyperpolarised gas MRI. Thorax 2012;67:613-617.
58. Gibbons WJ, Sharma A, Lougheed D, Macklem PT. Detection of excessive bronchoconstriction in asthma. Am J Respir Crit Care Med 1996;153(2):582-589. (Pubitemid 26051333)